Nystatin and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Nystatin (nystatin), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Levaquin, and have Hypersensitivity.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,568 Nystatin users. Check the latest studies of Nystatin.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,645 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

33,189 people reported to have side effects when taking Nystatin.
Among them, 29 people (0.09%) have Type 1 diabetes.

Among these 29 people:

How long have people been on Nystatin when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Nystatin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Type 1 diabetes when taking Nystatin? *

What are other drugs people take besides Nystatin? *

What are other side effects people have besides Type 1 diabetes? *

Constipation: 11 people, 37.93%
Depression: 11 people, 37.93%
Abdominal Pain: 10 people, 34.48%
Rashes (redness): 10 people, 34.48%
Fatigue (feeling of tiredness): 10 people, 34.48%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 34.48%
Hepatic Steatosis (fatty liver disease): 10 people, 34.48%
High Blood Pressure: 9 people, 31.03%
Anaemia (lack of blood): 8 people, 27.59%
Pleural Effusion (water on the lungs): 8 people, 27.59%

What are the existing conditions these people have? *

Hypersensitivity: 7 people, 24.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 17.24%
High Blood Cholesterol: 5 people, 17.24%
Breast Cancer Metastatic: 3 people, 10.34%
Pain: 3 people, 10.34%
Diabetes: 3 people, 10.34%
Metastatic Neoplasm (spreadable cancer tumour): 3 people, 10.34%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 6.90%
Bipolar Disorder (mood disorder): 2 people, 6.90%
Cough: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystatin:

Nystatin (33,568 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,846 reports)

Browse all side effects of Nystatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,645 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.